Financial reports
Current reports
6-K
Benitec Biopharma Appoints Edward Smith to the Board of Directors
15 Apr 20
6-K
Current report (foreign)
3 Apr 20
6-K
Position on FIRB approval
31 Mar 20
6-K
Court approves re-domiciliation scheme
30 Mar 20
6-K
Current report (foreign)
30 Mar 20
6-K
Results of Scheme Meeting
26 Mar 20
6-K
Current report (foreign)
18 Mar 20
6-K
Results for Announcement to the Market
26 Feb 20
6-K
Court orders convening of Scheme Meeting
7 Feb 20
6-K
Current report (foreign)
31 Jan 20
Registration and prospectus
15-12B
Securities registration termination
27 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 20
POS AM
Prospectus update (post-effective amendment)
15 Apr 20
POS AM
Prospectus update (post-effective amendment)
15 Apr 20
25
Voluntary exchange delisting
14 Apr 20
25-NSE
Exchange delisting
14 Apr 20
424B3
Prospectus supplement
17 Dec 19
F-1
Registration statement (foreign)
9 Dec 19
424B3
Prospectus supplement
24 Oct 19
424B5
Prospectus supplement for primary offering
30 Sep 19
Proxies
No filings
Other
EFFECT
Notice of effectiveness
17 Apr 20
EFFECT
Notice of effectiveness
17 Apr 20
EFFECT
Notice of effectiveness
17 Dec 19
CORRESP
Correspondence with SEC
12 Dec 19
UPLOAD
Letter from SEC
12 Dec 19
CT ORDER
Confidential treatment order
23 Nov 18
EFFECT
Notice of effectiveness
11 Dec 17
EFFECT
Notice of effectiveness
5 Jul 17
CORRESP
Correspondence with SEC
30 Jun 17
CT ORDER
Confidential treatment order
29 Jun 17
Ownership
SC 13G/A
Benitec Biopharma LTD/ADR
23 Jan 20
SC 13G/A
Benitec Biopharma LTD/ADR
13 Jan 20
SC 13G
Benitec Biopharma LTD/ADR
8 Oct 19
SC 13G
Benitec Biopharma LTD/ADR
7 Oct 19
SC 13G/A
Benitec Biopharma LTD/ADR
14 Feb 19
SC 13G
Benitec Biopharma LTD/ADR
9 May 18
SC 13D/A
Benitec Biopharma LTD/ADR
15 Mar 17
SC 13D/A
Benitec Biopharma LTD/ADR
3 Mar 17
SC 13G/A
Benitec Biopharma LTD/ADR
9 Jan 17
SC 13D
Benitec Biopharma LTD/ADR
1 Nov 16